Rita M. O'Connor
2019
In 2019, Rita M. O'Connor earned a total compensation of $1.1M as Chief Financial Officer at Dipexium Pharmaceuticals, a 129% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $192,500 |
|---|---|
| Option Awards | $505,831 |
| Salary | $347,917 |
| Other | $12,500 |
| Total | $1,058,748 |
O'Connor received $505.8K in option awards, accounting for 48% of the total pay in 2019.
O'Connor also received $192.5K in non-equity incentive plan, $347.9K in salary and $12.5K in other compensation.
Rankings
In 2019, Rita M. O'Connor's compensation ranked 9,029th out of 13,971 executives tracked by ExecPay. In other words, O'Connor earned more than 35.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,029 out of 13,971 | 35th |
Division Manufacturing | 3,616 out of 5,692 | 37th |
Major group Chemicals And Allied Products | 1,363 out of 2,189 | 38th |
Industry group Drugs | 1,161 out of 1,875 | 38th |
Industry Pharmaceutical Preparations | 857 out of 1,387 | 38th |
Source: SEC filing on September 25, 2020.
O'Connor's colleagues
We found three more compensation records of executives who worked with Rita M. O'Connor at Dipexium Pharmaceuticals in 2019.